Precision oncology is transforming cancer care by enabling therapies to be matched to the molecular characteristics of individual patients. As biomarker-driven development expands across tumor types, sponsors face increasing challenges in identifying eligible patients, optimizing trial execution and generating the evidence needed to support regulatory, reimbursement and clinical decision-making.
This webinar will explore strategies for advancing precision oncology across the development lifecycle. Topics will include the evolving biomarker landscape and testing approaches, innovative methods for identifying and recruiting biomarker-eligible patients through decentralized and hybrid trial models and the growing role of high-quality clinical data and real-world evidence in accelerating development and demonstrating value.
The discussion will also highlight how AI-enabled data extraction, linked clinical and genomic datasets and modern evidence-generation strategies are helping sponsors gain deeper insights, improve trial efficiency and support broader adoption of precision therapies.
Register for this webinar to learn how precision oncology strategies can strengthen biomarker-driven patient identification, trial execution and evidence generation.